Physician

Debbie Gladd Foley, D.O.

According to 2025 Medicare claims, Debbie Foley, D.O. (NPI: 1134140924) practices rheumatology in the Tulsa, OK market, with the plurality of this provider's patient population coming from Tulsa, OK. This provider's primary affiliated billing organization is PREMIER RHEUMATOLOGY OF OKLAHOMA (NPI: 1891282877; TIN: 82-1061303) and primary practice location at 74136-2117. Foley is affiliated with the Aledade 155 National MSSP (ACO ID: A5358), participating under the MSSP model.

Foley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 426 traditional Medicare patients, billed 358,622 HCPCS/CPT codes, and received $4,125,277 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,261 prescription claims across 329 beneficiaries totaling $843,834 in drug costs, led by Enbrel Sureclick (Etanercept). DME data shows 42 claims. Open Payments data shows 269 records totaling $60,407. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $141,591 to $4,125,277. In contrast, Part D prescription costs have declined steadily, from $1,577,206 to $843,834. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	271	11,927	$141,591
2016	251	15,464	$368,332
2017	233	65,323	$1,231,802
2018	221	76,040	$1,637,689
2019	243	104,569	$2,275,705
2020	255	151,708	$2,801,567
2021	271	145,121	$2,489,454
2022	381	327,418	$3,801,319
2023	394	386,128	$4,106,901
2024	426	358,622	$4,125,277

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	257	3,639	$1,577,206
2016	254	3,589	$2,124,935
2017	235	3,264	$2,030,997
2018	221	2,636	$1,719,748
2019	239	2,712	$1,684,350
2020	237	2,642	$1,200,276
2021	227	2,240	$1,162,777
2022	316	2,676	$995,321
2023	332	2,571	$988,984
2024	329	2,261	$843,834

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	42	$2,358

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	193	1,203	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	409	1,053	$92
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	157	601	$54
J0897	Injection, denosumab, 1 mg	134	12,480	$20
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	266	500	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	24	672	$190,449
Otezla	Apremilast	19	570	$99,302
Cimzia (2 Pack)	Certolizumab Pegol	11	308	$61,275
Actemra	Tocilizumab	13	364	$29,758
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	409	26,605	$16,805

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0823	Power wheelchair, group 2 standard, captains chair, patient weight capacity up to and including 300 pounds	Y	N/R	12	$1,372
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	18	$878
E1028	Wheelchair accessory, manual swingaway, retractable or removable mounting hardware for joystick, other control interface or positioning accessory	Y	N/R	12	$108

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	266	$43,110	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$17,297	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Debbie Gladd Foley, D.O.?

Tedicare shows public-source Medicare data for Debbie Gladd Foley, D.O. (NPI 1134140924), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Debbie Gladd Foley, D.O. have ACO affiliation data?

Debbie Gladd Foley, D.O. is shown with ACO affiliation data for Aledade 155 National MSSP (MSSP, ACO ID A5358).

What billing organization is linked to Debbie Gladd Foley, D.O.?

Debbie Gladd Foley, D.O. is linked to PREMIER RHEUMATOLOGY OF OKLAHOMA (billing NPI 1891282877) in the available physician profile data.

Does Debbie Gladd Foley, D.O. have Open Payments data?

Debbie Gladd Foley, D.O. has 269 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.